SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2. The ...

The past few weeks have been pretty huge for PC gaming hardware releases, and seemingly for some rather dubious claims from ...